[ET Net News Agency, 30 May 2023] KEYMED BIO-B (02162) rose 8.81% to HK$42.
It hits an intra-day high of HK$42.8, and an intra-day low of HK$39. The total shares
traded was 392,500, with a value of HK$16.18m. The active buy/sell ratio is 86:14, with
net buying turnover of HK$10.64m. MERRILL LYNCH FE accounts for greatest net responsive
buying turnover of HK$400,229, with volume weighted average price of HK$41.413. CHINA
INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$2.34m,
with volume weighted average price of HK$41.463.

Basic Information
=================

-----------------------------------
Nominal 42.000 % Chg +8.81%
High 42.800 Low 39.000
Shares Tr 392,500 Turnover 16.18m
10-D SMA 53.235 %H.V 106.367
20-D SMA 57.367 VWAP 41.217
50-D SMA 60.471 RSI14 26.711
-----------------------------------
Status: Active buy/sell ratio is 86:14, with net buying turnover of HK$10.64m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 42.00 +8.81
GENSCRIPT BIO (01548) 17.66 +1.49
INNOVENT BIO (01801) 36.60 +3.98
WUXI BIO (02269) 42.55 +1.31
TIGERMED (03347) 58.40 +1.65
BEIGENE (06160) 142.30 +3.04
ZAI LAB (09688) 24.40 +1.67
AKESO (09926) 33.65 +2.12
ALPHAMAB-B (09966) 8.15 +2.13
REMEGEN-B (09995) 35.05 +2.19
---------------------------------------------
(ed)